← Back to Treatments
🏅 FDA Orphan Designation

Survanta intratracheal suspension

Beractant

Manufacturer: Ross Laboratories

Indicated for:
Infant acute respiratory distress syndromeOrphan

FDA-Approved Indications (1)

Treatment of ("rescue") of premature infants with RDS confirmed by x-ray and requiring mechanical ventilation

Indications & Usage

INDICATIONS AND USAGE SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.

💙 Support Programs

View all →
Survanta intratracheal suspension
Ross Laboratories

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.